These clinical data contrast with the definition that higher expressions of IGF/IGF-IR are associated with higher aggressiveness and indicate that in some stages of cancer development, the transformation malignancy and unsatisfactory therapy response can be correlated with downregulation of IGF signaling. This evidence concerns the gene IGF1R and cancer.